Integra LifeScience made changes to the orthopedics and tissue technology business leadership and structure.
Spinal Tech
Aesculap Biologics announced that the first human implantation of its NOVOCART 3D product was performed in August.
The Food and Drug Administration granted 15 spine-related device clearances in August.
A new Reporterlink analysis examines the Asia Pacific minimally invasive spine surgery device market, which is expected to grow over the next several years.
Zacks recently named three potentially promising healthcare stocks despite changes from healthcare reform and the medical device excise tax.
Advertisement
Prison terms were given to two former ArthroCare executives for a fraud scheme that eventually cost shareholders $750 million, according to an FBI report.
K2M received 510(k) clearance from the U.S. Food and Drug Administration to market MESA Hooks — the latest implant addition to the MESA Deformity Spinal System — and also received CE Mark approval.
Ortho Development received U.S. Food and Drug Administration clearance for its Alpine Hip Stem.
The second quarter of the 2014 calendar year, or first quarter of the 2015 fiscal year, was big for several device companies, with mergers, acquisitions, new product releases and rumors to go around.
Arthrosurface received 510(k) clearance from the U.S. Food and Drug administration for the KISSloc Suture System.